Andrew Matthew Farland, MD
- Clinical Assistant Professor, Hematology and Oncology
Andrew Matthew Farland, MD
- Education
- MD, Virginia Commonwealth University School of Medicine, 2006
- Residency
- Internal Medicine, Wake Forest Baptist Medical Center, 2009
- Fellowship
- Hematology / Oncology, Wake Forest Baptist Medical Center, 2012
- Board Certifications
- American Board of Internal Medicine, Hematology
- American Board of Internal Medicine, Internal Medicine
- American Board of Internal Medicine, Medical Oncology
- Positions
- Clinical Assistant Professor, Hematology and Oncology
- Departments and Affiliations
- Hematology and Oncology
Research
- Implementation of Individualized Pain Care Plans Decreases Length of Stay and Hospital Admission Rates for High Utilizing Adults with Sickle Cell Disease. Welch-Coltrane JL, Wachnik AA, Adams MCB, Avants CR, Blumstein HA, Brooks AK, Farland AM, Johnson JB, Pariyadath M, Summers EC, Hurley RW. Pain Med. 2021 Mar;
- Effects of Shear Stress on Production of FVIII and vWF in a Cell-Based Therapeutic for Hemophilia A. Trevisan B, Morsi A, Aleman J, Rodriguez M, Shields J, Meares D, Farland AM, Doering CB, Spencer HT, Atala A, Skardal A, Porada CD, Almeida-Porada G. Front Bioeng Biotechnol. 2021; 9:639070.
- Defining the Optimal FVIII Transgene for Placental Cell-Based Gene Therapy to Treat Hemophilia A. El-Akabawy N, Rodriguez M, Ramamurthy R, Rabah A, Trevisan B, Morsi A, George S, Shields J, Meares D, Farland A, Atala A, Doering CB, Spencer HT, Porada CD, Almeida-Porada G. . 2020 Jun; 17:465-477.
- Acute Thrombotic Microangiopathy and Cortical Necrosis Following Administration of Alemtuzumab: A Case Report. Liou AA, Skiver BM, Yates E, Persad P, Meyer D, Farland AM, Rocco MV. Am. J. Kidney Dis. 2019 05; 73(5):615-619.
- Correlating S100B with disease course in a case of new onset, acquired thrombotic thrombocytopenic purpura (TTP): Could this be a new predictive biomarker in TTP?. Kuhlman P, Miller P, Farland A, Owen J, Batt K. J Clin Apher. 2018 Aug; 33(4):541-545.